Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
07/2000
07/26/2000EP1021533A1 Nucleic acids coding for proteins capable of interacting with presenilins
07/26/2000EP1021201A1 Use of growth differenciation factor-9 (gdf-9) as a contraceptive
07/26/2000EP0870063B1 Fluorescence detection assay for homogeneous pcr hybridization systems
07/26/2000EP0793830A4 Improved accuracy in cell mitosis analysis
07/26/2000EP0755458A4 Electrogenerated chemiluminescence labels for analysis and/or referencing
07/26/2000EP0720615B1 Elongation, amplification and sequence determination using a chimeric oligonucleotide
07/26/2000CN1261407A Method based on use of bacteriophages for detection hiological molecules in biological samples
07/26/2000CN1261406A Reverse transcription method
07/26/2000CN1261403A Surface exposed proteins from chlamydia pneumoniae
07/26/2000CN1261252A Soybean having epistatic genes affecting yield
07/25/2000US6093811 Oligonucleotide modulation of cell adhesion
07/25/2000US6093808 IκBEGFP constructs, cell lines and methods of use
07/25/2000US6093728 Methods of modulating serine/threonine protein kinase function with azabenzimidazole-based compounds
07/25/2000US6093695 Bacillus thuringiensis CryET29 compositions toxic to coleopteran insects and ctenocephalides SPP
07/25/2000US6093561 Human lysophospholipase
07/25/2000US6093553 Immortalized brain endothelial cells
07/25/2000US6093552 Kit comprising a conjugate of a pure cloned chitinase enzyme and a label selected from a radiactive material, fluorescent material, a dye, and an enzyme, the conjugate binds to yeast chitin but not cellulose or glucan; and filter to retain cell
07/25/2000US6093549 Identifying candidate therapeutic agents which interfere with huntingtin associated protein-1(hap1) and huntingtin binding by contacting these proteins and a compound, determining if the compound diminishes the two proteins from binding
07/25/2000US6093545 Contacting the sample with nucleic acid probe or primer and detecting hybridization to the target nucleic acid; diagnosis of nervous system disorders including eating and sleep disorders, irritable bowel and glandular disorders
07/25/2000US6093544 Rupestris stem pitting associated virus nucleic acids, proteins, and their uses
07/25/2000US6093542 Isothermal transcription based amplification assay for the detection and quantitation of macrophage derived chemokine RNA
07/25/2000US6093541 With metal presentation surface having immobilized complex of tethering molecule and digestion molecule; for rapid and efficient analysis of biomolecules using matrix-assisted laser desorption/ionization technique
07/25/2000US6093538 Nucleotide sequences of 10 to 100 nucleotides in length for rapid detection of urogenital bacteria linked to disorders
07/25/2000US6093537 Detecting target sequence in sample by mixing with pair of nucleotide sequences, hybridizing, attaching nucleotide sequences together, adding nucleotide sequence specific binding proteins, and detecting binding
07/25/2000US6093535 By analyzing genomic dna present in a sample of varicella virus and determining if dna satisfies eight characteristics
07/25/2000US6093370 Different probes having a specific base sequence are immobilized to independent areas formed on the surface of a substrate, complementary polynucleotides in a sample are hybridized to the probe, heating, cooling, and extracting
07/25/2000US6092764 Interface seal for an aircraft
07/25/2000CA2109727C Tumor rejection antigen precursors, tumor rejection antigens and uses thereof
07/20/2000WO2000042561A2 Oligonucleotide mediated nucleic acid recombination
07/20/2000WO2000042560A2 Methods for making character strings, polynucleotides and polypeptides
07/20/2000WO2000042422A1 Disposable test strips with integrated reagent/blood separation layer
07/20/2000WO2000042223A1 Method for controlling the distribution of dna sequencing termination products
07/20/2000WO2000042222A2 Immobilized nucleic acid hybridization reagent and method
07/20/2000WO2000042221A2 Method for the affinity isolation of newly synthesized rna
07/20/2000WO2000042220A1 Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
07/20/2000WO2000042219A1 Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
07/20/2000WO2000042218A1 Retinol binding protein 4 as a genetic marker for increased litter size
07/20/2000WO2000042217A2 Method for electrochemically detecting nucleic acid-oligomer hybridisation events
07/20/2000WO2000042216A2 Genetic predisposition to abnormal calcification conditions
07/20/2000WO2000042215A1 Method and polynucleotides for determining translational efficiency of a codon
07/20/2000WO2000042214A1 Phosphate release enzyme assay
07/20/2000WO2000042213A1 A novel method for designing protein kinase inhibitors
07/20/2000WO2000042212A1 Optimized high-throughput analytical system
07/20/2000WO2000042211A1 Methods of screening protease inhibitors, of inducing mice susceptible to hiv protease inhibitor-induced dyslipidemia, and genes associated therewith
07/20/2000WO2000042210A2 Microsatellite dna markers and uses thereof
07/20/2000WO2000042209A1 Methods and apparatus for detecting polynucleotide hybridization
07/20/2000WO2000042208A1 Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use
07/20/2000WO2000042205A2 Herbicide target gene and methods
07/20/2000WO2000042204A2 Trans-acting factors in yeast
07/20/2000WO2000042202A1 A method for introducing substances into cells, and use of said method
07/20/2000WO2000042201A2 Human peptidases
07/20/2000WO2000042199A1 Biologically active reverse transcriptases
07/20/2000WO2000042181A1 Minor histocompatibility antigens and their use in diagnosis and treatment of tumors
07/20/2000WO2000042177A1 Method for isolating dna from biological materials
07/20/2000WO2000042172A2 Human homologues of proteins regulated by circadian rhythms
07/20/2000WO2000042170A1 Novel lrsg protein and nucleic acid molecules and uses therefor
07/20/2000WO2000042167A1 Eukaryotic cell-based system for identifying gene modulators
07/20/2000WO2000042165A2 Bone marrow-specific protein
07/20/2000WO2000042064A1 Peptides for inhibiting hpv e6 proteins
07/20/2000WO2000042042A2 High affinity inhibitors for target validation and uses thereof
07/20/2000WO2000041610A2 Mitochondrial dna damage as a predictor of coronary atherosclerotic heart disease
07/20/2000WO2000041566A1 Regulation of endogenous gene expression in cells using zinc finger proteins
07/20/2000WO2000041561A1 Bacterial cell component-unresponsive model mouse
07/20/2000WO2000041558A2 Interspecific nicotiana hybrids and their progeny
07/20/2000WO2000041549A2 Binary probe and clamp composition and methods for target hybridization detection
07/20/2000WO2000041524A2 Isothermal amplification of dna
07/20/2000WO2000041516A2 Reagents and methods useful for detecting diseases of the breast
07/20/2000WO2000041497A2 Use of apoptosis inducing agents in the treatment of (auto)immune diseases
07/20/2000WO2000041472A2 Binding partners for 5-ht5-receptors for the treatment of migraine
07/20/2000WO2000020629A3 Quantitation of rna
07/20/2000WO2000020590A3 G-protein coupled receptor proteins
07/20/2000WO2000017358A3 Human chaperone proteins
07/20/2000WO2000017235A3 Cytokine receptor zalpha11
07/20/2000WO2000013017A3 Method and device for producing and/or analyzing biochemical reaction supporting materials
07/20/2000WO2000011446A3 Signal generating oligonucleotide-based biosensor
07/20/2000WO2000004156A9 SEROTYPE-SPECIFIC PROBES FOR $i(LISTERIA MONOCYTOGENES)
07/20/2000WO2000004149A3 Compositions and methods for therapy and diagnosis of prostate cancer
07/20/2000WO2000003727A9 Engineered proteins for analyte sensing
07/20/2000WO2000003246A9 A system for cell-based screening
07/20/2000WO2000002897A9 Delta cleavage products and methods based thereon
07/20/2000WO1999064835A9 Screening method for dehydrogenase oligomerisation modulators
07/20/2000WO1999064048A9 Inhibitors of hiv reverse transcriptase
07/20/2000WO1999054353A3 Human nucleic acid sequences of normal uterus tissue
07/20/2000WO1999049293A8 Methods, kits and compositions pertaining to detection complexes
07/20/2000WO1999024824A9 Measuring device comprising a sampling cell and used for detecting small amounts of samples in liquids
07/20/2000WO1997025042A8 Use of an agonist of ppar-alpha and ppar-gamma for the treatment of syndrom x
07/20/2000DE19901008A1 Peptide zur Inhibierung von HPV E6-Proteinen Peptides for inhibition of HPV-E6 proteins
07/20/2000DE19855013A1 Androgen- und Progesteron-Rezeptor bindendes Hormon Response Element Androgen and progesterone receptor binding hormone response element
07/20/2000CA2721213A1 A system for generating labels from sequences of biological molecules
07/20/2000CA2509345A1 Bacterial cell component-unresponsive model mouse
07/20/2000CA2375769A1 Isothermal amplification of dna
07/20/2000CA2371938A1 Method for electrochemically detecting nucleic acid-oligomer hybridisation events
07/20/2000CA2362484A1 Herbicide target gene and methods
07/20/2000CA2361189A1 Retinol binding protein 4 as a genetic marker for increased litter size
07/20/2000CA2360597A1 Mitochondrial dna damage as a predictor of coronary atherosclerotic heart disease
07/20/2000CA2360588A1 Human homologues of proteins regulated by circadian rhythms
07/20/2000CA2360581A1 A novel method for designing protein kinase inhibitors
07/20/2000CA2360464A1 Human peptidases
07/20/2000CA2360013A1 Optimized high-throughput analytical system
07/20/2000CA2359814A1 Method for the affinity isolation of newly synthesized rna